<?xml version="1.0" encoding="UTF-8"?>
<ref id="B143-molecules-24-01913" class="ref">
 <label class="label">143.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Schlich</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Fornasier</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Nieddu</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sinico</surname>
    <given-names class="given-names">C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Murgia</surname>
    <given-names class="given-names">S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Rescigno</surname>
    <given-names class="given-names">A.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">3-hydroxycoumarin loaded vesicles for recombinant human tyrosinase inhibition in topical applications</article-title>
  <source class="source">Colloids Surf. B Biointerfaces</source>
  <year class="year">2018</year>
  <volume class="volume">171</volume>
  <fpage class="fpage">675</fpage>
  <lpage class="lpage">681</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.colsurfb.2018.08.008</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">30107341</pub-id>
 </element-citation>
</ref>
